EndaCof-PD and Risankizumab-rzaa topical
Determining the interaction of EndaCof-PD and Risankizumab-rzaa topical and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: brompheniramine / dextromethorphan / guaifenesin / phenylephrine
Brand name: AccuHist PDX Syrup, Allanhist PDX Syrup, Bromhist-PDX, EndaCof-PD, Uni-Hist PDX Syrup
Synonyms: n.a.
Generic Name: risankizumab
Brand name: Skyrizi
Synonyms: Risankizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- EndaCof-PD-Risedronate
- EndaCof-PD-Risedronate and Calcium
- EndaCof-PD-Risedronate Delayed Release
- EndaCof-PD-Risedronate Delayed-Release Tablets
- EndaCof-PD-Risedronate Sodium
- EndaCof-PD-Risedronate Tablets
- Risankizumab-rzaa topical-Endal CD Syrup
- Risankizumab-rzaa topical-Endocet
- Risankizumab-rzaa topical-Endocet 10/325
- Risankizumab-rzaa topical-Endocet 2.5/325
- Risankizumab-rzaa topical-Endocet 5/325
- Risankizumab-rzaa topical-Endocet 7.5/325